Bio Saga Blog - A Chronicle of Life Sciences & Informatics

Accelrys has bought Qumas, a provider of cloud-based and on-premise enterprise compliance software for regulatory and quality operations in regulated industries including the life sciences, for $50 million. Accelrys said that the added intellectual property extends its informatics portfolio by providing document and process management compliance solutions that improve its ability to help customers reduce regulatory risks and quality costs, improve compliance, and increase operational efficiency across their product development lifecyles. Operating from offices in Cork, Ireland and New Jersey, Qumas provides an electronic document management application with related research and development submission and QA documentation packages based on customer and industry requirements and best practices. Its business process management applications include corrective action/preventive action, audit, change control, deviation, complaint, and more. For the last two decades, the company has been ...

Illumina today announced it signed a definitive agreement to acquire clinical software firm NextBio. NextBio, based in Santa Clara, Calif., provides platforms to aggregate and analyze large amounts of phenotypic and genomic data for research and clinical applications. It currently has customers at more than 50 commercial entities and academic institutions. By acquiring the firm, Illumina "will be able to offer customers enterprise-level bioinformatics solutions that accelerate the discovery of new associations between the human genome and disease, and ultimately, enable the application of those discoveries within healthcare," according to a company statement. NextBio's platform allows customers to compare experimental data against existing data sets using a correlation engine, enabling them to discover new associations. It uses "highly scalable" software-as-a-service enterprise technology and is capable of analyzing petabytes of data. Illumina plans ...

Qiagen has acquired CLC Bio, a privately held bioinformatics software company headquartered in Aarhus, Denmark. The news was first reported on AllSeq's blog . This is the second bioinformatics company that Qiagen has purchased this year. In May, it bought Ingenuity Systems for $105 million in cash to offer its life science and clinical customers a complete and integrated workflow for its PCR- and next-generation sequencing-based molecular testing solutions ( BI 5/3/2013 ). Qiagen has been making some interesting moves lately, slowly building an end to end sequencing solution. They’ve already established themselves as the market leaders in sample prep, but then they started acquiring the missing pieces. First they bought Intelligent BioSystems in June 2012, giving them access to a sequencing platform built with the clinical market in mind (fairly standard SBS chemistry, relatively fast runs and multiple flow cells to obviate the need for sample multiplexing). Then they ...

PerkinElmer Reduces Headcount by More than 400 in 2012 PerkinElmer reduced its workforce by 62 employees during the first quarter as part of a restructuring plan, PerkinElmer Lays off 265 in Second Quarter PerkinElmer laid off 265 employees during the second quarter, the company said in its Form 10-Q today. In the document filed with the US Securities and Exchange Commission, it said that the reduction in workforce was part of a restructuring plan to move some of its operations into a newly established shared service center and to realign operations, R&D resources, and production resources as a result of previous acquisitions. During the company's recent second quarter earnings conference call , PerkinElmer Chairman and CEO Robert Friel said that the firm had consolidated three North American facilities, "and efforts are underway to consolidate two additional legacy Caliper sites, further simplifying our operational footprint and improving our R&D effi...

Courtesy Xconomy After merging with Symyx Technologies in 2010, acquiring Contur Sofware in 2011, and buying VelQuest earlier this year, San Diego scientific software developer Accelrys says today it is buying Aegis Analytical. Accelrys is paying $30 million in cash for Aegis, a company based in Lafayette, CO, (near Boulder) that makes software used to monitor biotech product development and manufacturing processes. In a  statement  today, Accelrys says the deal helps to further expand its suite of software used to manage the life cycle of innovation among pharmaceutical companies and in other industries. Aegis has about 40 full-time and contract employees, and “the idea is to keep the business in Boulder and fairly intact,” Accelrys CFO Michael Piraino told me during a phone interview earlier this afternoon. Aegis CEO Robert Di Scipio will stay with the merged company through the transition to new ownership. About two-thirds of Acce...

This is getting interesting every day! I love this Idea! sell a company but before selling it split or spin off as another company with a future technology (Illumina). After a few years again sell or get acquired! Citing vast future potential, ISS has sided with Illumina in the gene-sequencing company’s fight to hold off a hostile bid from Roche Holding. The proxy advisor says shareholders should vote the Illumina board back into service, and reject Roche’s slate because the offer probably undervalues the future of Illumina. Roche  last week raised its offer for Illumina to $51 a share from $44.50 , and called it fair and full. But Illumina shares immediately went above $51, and some in the market have pointed to $60 as the number to get the deal done. Illumina rejected the offer,  citing a report that compared the company to Apple and Illumina’s products to iPads.  The company has argued that Roche’s bid came just after Illumina’s own shares had cratered on a ba...

1. Post :  Business Analyst in Pharmaceutical Research Experience :  0 to 2 yrs Job Desciption : a. Track the pharmaceutical, biotech and medical devices industry, especially therapeutic areas/modalities of interest to our regular clients b. Understand project brief given by clients/project leaders, create analysis plan, data requirements, research approach, and prepare reports or executive presentations with key insights and recommendations c. Report to project leader/consultant and assist in executing or execute the projects completely depending on complexity and scale Education :  M.Sc – Bio-Chemistry, Biotechnology, Life Science Salary : INR 1,75,000 – 2,50,000 P.A. The CTC is exclusive of Performance Bonus Desirable : a. High level of comfort with MS Excel, Power Point, ability to perform basic calculations (basic financial, statistical and data manipulation) understand sales and marketing performance metrics, basic data cleaning and organizing, ability...

Genbios welcomes talented and committed people who wish to work alongside the best minds. If you hold a Ph.D or a Masters in Bioinformatics, Biotechnology, Microbiology, Software Engineering and Business Management, we invite you to be a part of the Genbios team. Please email your resume only to  info@genbios.in Current vacancies: Data curator and Analyst Qualification:  Graduate/ Post-graduate/ Diploma in Bioinformatics The job profile includes Literature survey Collection and curation biological data Bioinformatics analysis of data Database creation and management Skill set: Bioinformatics: A complete knowledge of the most commonly used bioinformatics databases and tools Information Science: Good knowledge in application of various programming languages such as Perl, Perl-CGI, Java, MySQL, PHP and related technologies for Bioinformatics. Experience in Linux environment is an advantage Life sciences: A very sound basic knowledge of biology is necessary. Good communicat...

Opportunity for Freshers as Medical Editor post at Cactus Communications, Mumbai Cactus Communications is a pioneering language services company serving more than 25,000 clients across 73 countries. In line with its mission—growth through effective communication, Cactus offers specialist academic editing, medical communications, publication support, transcription, and training services to individuals and corporations across sectors such as academia, publishing, and pharmaceuticals.  Candidates with scientific field degree apply for Specialist – CSD Job at Novartis A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes us one of the most rewarding employers in our field. Designation : Specialist – CSD Job Description Freshers jobs at Jubilant LifeSciences – Biotech/ Biochem/ Microbiology Jubilant Biosys Ltd, ...

3 Industry facilities open for Internship & Live Projects, 2 well equipped labs providing Drug Discovery Internships; 1 providing hands on live training and live project on NGS & microarray data analysis who can benefit? 1) Industry people who wish to upgrade and equip themselves 2) Researchers in research facilities, govt. & academics 3) Students & Freshers (Job assistance provided) for more info write to jkamesh@gamil.com

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, announced today the acquisition of the business assets of  Ariadne Genomics , a provider of pathway analysis tools and semantic technologies for life science researchers. Ariadne will be integrated with Elsevier's Corporate Markets division. "Ariadne Genomics' pathway analysis tools and semantic technologies integrate research findings from across multiple content sources providing a deeper understanding of biological pathways and disease progression. Ariadne's products improve research productivity and outcomes for life science researchers by delivering new insights for potential interventions, therapies and cures," said Alexander van Boetzelaer, Managing Director of Elsevier Corporate Markets. "Ariadne brings to Elsevier an information offering in the biology domain and a passionate and dedicated team of life science professionals. Ariadne's team ...

For Indian laboratories, the decision to implement  informatics applications that support compliance with 21 CFR Part 11 delivers multiple benefits. They are protecting their access to regulated markets in the US and other countries while implementing electronic processes and procedures that can reduce costs while enhancing their ability to deliver world class results.

PerkinElmer is pleased to announce that today it completed the acquisition of Caliper Life Sciences, an exciting milestone in PerkinElmer’s evolution. The purchase, announced in September . Bringing Caliper into PerkinElmer will significantly strengthen leadership position in the growing area of personalized medicine, providing pharmaceutical companies and clinicians with the tools and knowledge they need to enable individualized diagnoses and treatments. PKI's work moving ahead in this emerging field will be made possible by an outstanding team of people from Caliper and PerkinElmer collaborating together to leverage the combined power of their knowledge and expertise to deliver insight-driven innovations. Bio-discovery and Caliper will combine to form PerkinElmer’s new Life Sciences & Technology (LST) Strategic Business Element (SBE). In a statement today, Robert Friel, chairman and CEO of PerkinElmer, said that he is confident that joining together these two organization...

PerkinElmer reported after the close of the market on Thursday that revenues in the third quarter rose 8 percent year over year, but it missed analyst estimates on the top line. Total revenues in the quarter ended Oct. 2 rose to $453.7 million, compared to $419.1 million a year ago but fell short of Wall Street estimates of $469.6 million. On an organic basis, revenues were up 4 percent year over year. The firm has made a number of purchases throughout 2011 and in the quarter those acquisitions contributed more than $20 million to the top line, CFO Frank Wilson said on a conference call after the release of the company's earnings results. The Human Health segment grew revenues to $207.4 million, up 7 percent from $194.5 million a year ago, while Environmental Health climbed to $246.3 million, a 10 percent increase from $224.6 million a year ago. On the conference call, Chairman and CEO Robert Friel said that during the quarter, growth was seen across all major geographies and most ...

Just out of school with an MSc, Btech, BE, Mtech and you feel that there is a huge gap between your skill set and the education qualification you have in hand. How to really prepare yourselves for a job as soon as you finish and have your degrees in hand? Your employer expects you to be productive from day one and to be contributing to any of the on-going projects of the organization. So what are the odds on your side to be picked up for a job?   So buckle your shoe and prepare to be absorbed by the industry. Finishing schools already clichéd! BioSaga Buckle Your Shoe Programmes are 100% hand on workshops which provide near to industry exposure in two most sought-after areas in the Life Science/Bio/BioPharma & Pharma Industry: BioSaga Drug Discovery BioSaga Genomics Contact lukeskywaran@aol.com for more information    

Courtesy jobsinsciences.com Research Associate position Molecular Biology at Piramal Life Sciences Research Associate Piramal Life Sciences Ltd Experience: 1 – 2 Years Compensation:Rupees 2,00,000 – 2,25,000 Education: UG – B.Sc – Bio-Chemistry,B.Tech/B.E. – Bio-Chemistry/Bio-Technology PG – M.Sc – Bio-Chemistry,M.Tech – Bio-Chemistry/Bio-Technology Job Description • Responsible for performing research and development experiments for projects and products, in collaboration with others. • Regularly exercises technical discretion in the [...] Principal Investigator/ Senior Principal Investigator – Neuroscience at Syngene International Ltd Principal Investigator/Senior Principal Investigator for Neuroscience Syngene International Limited Experience: 5 – 10 Years Compensation:Rupees 6,00,000 – 9,00,000 Education:UG – Any Graduate – Any Specialization,Graduation Not Required PG – Any PG Course – Any Specialization,Post Graduation Not Required Job Description Qualification: Ph.D. in P...

Shares of Gen-Probe jumped 14 percent today after  Bloomberg  reported that the firm has hired Morgan Stanley to seek a buyer. Among the possible bidders listed in the article are Novartis, Thermo-Fisher Scientific, Danaher, and Life Technologies. Novartis already sells Gen-Probe's Tigris blood-screening instrument to blood banks, and it has  helped fund development  of Gen-Probe's new automated molecular testing platform, called Panther. The firms have collaborated since 1998 on nucleic acid tests and instruments for the blood screening market. According to Mizuho analyst Peter Lawson, around $12 billion has been spent on diagnostics-focused merger and acquisition activity over the past year. He noted that typical molecular and proprietary-focused acquisition valuations fall into the 3x-6x price/sales range. Two months ago, Gen-Probe  reported full-year 2010 revenues  of $543.3 million. At that time, it also reported a 2 percent decrease in fourt...